Literature DB >> 1374604

Peri- and postoperative changes in serum levels of four tumor markers and three acute phase reactants in benign and malignant gynecological diseases.

E Avall-Lundqvist1, K Sjövall, L O Hansson, P Eneroth.   

Abstract

Serum levels of squamous cell carcinoma antigen, carcinoembryonic antigen, CA 125, tissue polypeptide antigen, CRP, alpha 1-antitrypsin and haptoglobin were determined peri- and postoperatively in patients undergoing surgery for benign gynecological disease (n = 18) and postoperatively in women operated for cervical carcinoma (n = 23). The only significant changes seen after premedication, during anesthesia and during surgery were a decrease in serum concentrations of alpha 1-antitrypsin and haptoglobin. We found no postoperative changes in the serum levels of squamous cell carcinoma antigen nor in carcinoembryonic antigen values. However, the latter analyte was influenced by smoking habits. Elevated levels of CA 125 and tissue polypeptide antigen were found in the cancer patients, predominantly within the first 1-3 weeks after surgery. These levels decreased to normal values within 4-6 weeks postoperatively. The median intraindividual coefficients of variation for the tumor markers ranged between 15% and 28% in 30 control women not having surgery. In general, it would seem advisable to wait 6 weeks after surgery before monitoring with CA 125 and TPA is started.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374604     DOI: 10.1007/bf02759914

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  20 in total

1.  Temporary elevation of CA 125 after abdominal surgical treatment for benign disease and cancer.

Authors:  R W Talbot; D J Jacobsen; D M Nagorney; G D Malkasian; R E Ritts
Journal:  Surg Gynecol Obstet       Date:  1989-05

2.  Increased carcinoembryonic antigen in heavy cigarette smokers.

Authors:  D P Stevens; I R Mackay
Journal:  Lancet       Date:  1973-12-01       Impact factor: 79.321

3.  Distribution of tissue polypeptide antigen (TPA) in normal human tissues: Immunohistochemical study on unfixed, methanol-, ethanol-, and formalin-fixed tissues.

Authors:  W B Nathrath; P Heidenkummer; V Björklund; B Björklund
Journal:  J Histochem Cytochem       Date:  1985-02       Impact factor: 2.479

4.  Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization.

Authors:  T Maruo; K Shibata; A Kimura; M Hoshina; M Mochizuki
Journal:  Cancer       Date:  1985-07-15       Impact factor: 6.860

Review 5.  Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation.

Authors:  H Baumann; J Gauldie
Journal:  Mol Biol Med       Date:  1990-04

Review 6.  C-reactive protein and the acute phase response.

Authors:  H Gewurz; C Mold; J Siegel; B Fiedel
Journal:  Adv Intern Med       Date:  1982

7.  Maternal and cord serum levels of tissue polypeptide antigen (TPA) in normal pregnancies.

Authors:  K Bremme; P Eneroth; B Nilsson; M Olsson
Journal:  Gynecol Obstet Invest       Date:  1985       Impact factor: 2.031

8.  The effect of hysterectomy on serum CA 125 levels in patients with adenomyosis and uterine fibroids.

Authors:  H Halila; A M Suikkari; M Seppälä
Journal:  Hum Reprod       Date:  1987-04       Impact factor: 6.918

9.  Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker.

Authors:  P A Canney; M Moore; P M Wilkinson; R D James
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640

10.  Squamous cell carcinoma antigen for monitoring cervical cancer.

Authors:  P Schmidt-Rhode; K D Schulz; G Sturm; H Häfner; H Prinz; H J Künzig
Journal:  Int J Biol Markers       Date:  1988 Apr-Jun       Impact factor: 3.248

View more
  1 in total

Review 1.  A systematic review of the association between circulating concentrations of C reactive protein and cancer.

Authors:  Katriina Heikkilä; Shah Ebrahim; Debbie A Lawlor
Journal:  J Epidemiol Community Health       Date:  2007-09       Impact factor: 3.710

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.